BridgeMD
Compares treatment options for Hip Osteoarthritis
Official title Platelet Rich Plasma Versus Corticosteroids in Hip Osteoarthritis Pain
ClinicalTrials.gov ID: NCT06793982
What this study is testing
What is Corticosteroid Injection?
Corticosteroid Injection is an investigational medicine, given as an injectable medicine, being studied as a potential treatment for hip osteoarthritis.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Prospective, single-center that may go on to being multicenter, randomized trial comparing platelet rich plasma (PRP) versus corticosteroid injection for the treatment of symptoms of Hip osteoarthritis. The purpose of the study is to determine which therapy provides a greater reduction in patient reported outcome measures of pain and function.
- Phase 4: studies an already-approved treatment
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 21 to 80
You may be able to join if
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Male or female, aged 21-80 years
- Radiographic diagnosis of Kellgren-Lawrence (KL) grade of II or III Hip osteoarthritis
- Indicated for a Hip injection to treat Hip OA symptoms
You likely can't join if
- Any injections into the target Hip within three months
- Current overlying skin infection
- Current or previous diagnosis of "chronic pain"
- Opioid tolerant at time of screening (for a week or longer, at least 60 mg of morphine daily, or at least 30 mg of oral oxycodone daily, or at least...
- Allergy to any potential ingredients or medications utilized in any of the two groups
- Treatment with another investigational drug or other intervention for pain
See the full eligibility criteria
- Provision of signed and dated informed consent form
- Stated willingness to comply with all study procedures and availability for the duration of the study
- Male or female, aged 21-80 years
- Radiographic diagnosis of Kellgren-Lawrence (KL) grade of II or III Hip osteoarthritis
- Indicated for a Hip injection to treat Hip OA symptoms
- Any injections into the target Hip within three months
- Current overlying skin infection
- Current or previous diagnosis of "chronic pain"
- Opioid tolerant at time of screening (for a week or longer, at least 60 mg of morphine daily, or at least 30 mg of oral oxycodone daily, or at least 8 mg of oral hydromorphone daily or an equianalgesic dose of another...
- Allergy to any potential ingredients or medications utilized in any of the two groups
- Treatment with another investigational drug or other intervention for pain
- Diagnosis of Diabetes Mellitus
- If female, pregnant or planning to be pregnant within the following 3 months or study duration
- Any condition(s) or diagnosis, both physical or psychological, or physical exam finding in the opinion of the investigator that would precludes participation
The study team makes the final eligibility decision.
Where it's taking place
- Baltimore, Maryland, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 21 years to 80 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Baltimore, Maryland, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.